AUPP913999A0 - Novel chemical compounds and their use - Google Patents

Novel chemical compounds and their use

Info

Publication number
AUPP913999A0
AUPP913999A0 AUPP9139A AUPP913999A AUPP913999A0 AU PP913999 A0 AUPP913999 A0 AU PP913999A0 AU PP9139 A AUPP9139 A AU PP9139A AU PP913999 A AUPP913999 A AU PP913999A AU PP913999 A0 AUPP913999 A0 AU PP913999A0
Authority
AU
Australia
Prior art keywords
chemical compounds
novel chemical
novel
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP9139A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Priority to AUPP9139A priority Critical patent/AUPP913999A0/en
Publication of AUPP913999A0 publication Critical patent/AUPP913999A0/en
Priority to IL14534600A priority patent/IL145346A/xx
Priority to JP2000605578A priority patent/JP5160000B2/ja
Priority to AT00907354T priority patent/ATE295361T1/de
Priority to MXPA01009203A priority patent/MXPA01009203A/es
Priority to NZ514041A priority patent/NZ514041A/xx
Priority to BR0008939-7A priority patent/BR0008939A/pt
Priority to KR1020017011546A priority patent/KR100805906B1/ko
Priority to AU28966/00A priority patent/AU774222B2/en
Priority to PCT/AU2000/000165 priority patent/WO2000055149A1/en
Priority to HU0200190A priority patent/HUP0200190A3/hu
Priority to HK02103316.9A priority patent/HK1041693B/en
Priority to IDW00200101979A priority patent/ID29868A/id
Priority to EA200100968A priority patent/EA200100968A1/ru
Priority to CZ20013274A priority patent/CZ20013274A3/cs
Priority to DE60020100T priority patent/DE60020100T2/de
Priority to PL00350228A priority patent/PL350228A1/xx
Priority to EP00907354A priority patent/EP1165541B1/en
Priority to ES00907354T priority patent/ES2241581T3/es
Priority to CN00804901A priority patent/CN1343205A/zh
Priority to CA002367755A priority patent/CA2367755C/en
Priority to APAP/P/2001/002277A priority patent/AP2001002277A0/en
Priority to TR2001/02794T priority patent/TR200102794T2/xx
Priority to TW089118492A priority patent/TWI268279B/zh
Priority to US09/658,445 priority patent/US6548476B1/en
Priority to ZA200107450A priority patent/ZA200107450B/xx
Priority to NO20014409A priority patent/NO327812B1/no
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPP9139A 1999-03-12 1999-03-12 Novel chemical compounds and their use Abandoned AUPP913999A0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
AUPP9139A AUPP913999A0 (en) 1999-03-12 1999-03-12 Novel chemical compounds and their use
TR2001/02794T TR200102794T2 (tr) 1999-03-12 2000-03-09 Dimerik bileşimler, bunların nöraminidaz inhibitörü olarak kullanımı
IDW00200101979A ID29868A (id) 1999-03-12 2000-03-09 Senyawa-senyawa dimer dan penggunaannya sebagai penghambat neuraminidase
CZ20013274A CZ20013274A3 (cs) 1999-03-12 2000-03-09 Dimerní sloučeniny jako inhibitory neuraminidasy
AT00907354T ATE295361T1 (de) 1999-03-12 2000-03-09 Dimerverbindungen und als inhibitoren der neuramidinase
MXPA01009203A MXPA01009203A (es) 1999-03-12 2000-03-09 Compuestos dimericos y como inhibidores de neuraminidasa.
NZ514041A NZ514041A (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase
BR0008939-7A BR0008939A (pt) 1999-03-12 2000-03-09 Composto dimérico, composição farmacêutica,processo para o tratamento ou profilaxia de, umainfecção por ortomixovìrus ou paramixovìrus emum mamìfero, utilização de composto e processode detecção do vìrus da influenza
KR1020017011546A KR100805906B1 (ko) 1999-03-12 2000-03-09 이량체 화합물 및 뉴라미니다제 억제제로서의 용도
AU28966/00A AU774222B2 (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase
PCT/AU2000/000165 WO2000055149A1 (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase
HU0200190A HUP0200190A3 (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them
HK02103316.9A HK1041693B (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase
IL14534600A IL145346A (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase
EA200100968A EA200100968A1 (ru) 1999-03-12 2000-03-09 Димерные соединения и их применение в качестве ингибиторов нейраминидазы
JP2000605578A JP5160000B2 (ja) 1999-03-12 2000-03-09 二量体化合物およびニューラミニダーゼ阻害剤として
DE60020100T DE60020100T2 (de) 1999-03-12 2000-03-09 Dimerverbindungen und ihre Verwendung als Inhibitoren der Neuraminidase
PL00350228A PL350228A1 (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase
EP00907354A EP1165541B1 (en) 1999-03-12 2000-03-09 Dimeric compounds and as inhibitors of neuraminidase
ES00907354T ES2241581T3 (es) 1999-03-12 2000-03-09 Compuestos dimericos y su uso como inhibidores de neuraminidasa.
CN00804901A CN1343205A (zh) 1999-03-12 2000-03-09 二聚化合物及其作为神经氨酸酶抑制剂
CA002367755A CA2367755C (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase
APAP/P/2001/002277A AP2001002277A0 (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase.
US09/658,445 US6548476B1 (en) 1999-03-12 2000-09-08 Dimeric inhibitors of influenza neuraminidase
TW089118492A TWI268279B (en) 1999-03-12 2000-09-08 Dimeric anti-viral agents and methods for preparation and use thereof
ZA200107450A ZA200107450B (en) 1999-03-12 2001-09-10 Dimeric compounds and their use as inhibitors of neuraminidase.
NO20014409A NO327812B1 (no) 1999-03-12 2001-09-11 Dimere forbindelser, slike forbindelser som farmasoytiske midler, farmasoytiske preparater inneholdende slike, anvendelse av slike for fremstilling av medikamenter for behandling av sykdom samt en in vitro metode for pavisning av influensavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP9139A AUPP913999A0 (en) 1999-03-12 1999-03-12 Novel chemical compounds and their use

Publications (1)

Publication Number Publication Date
AUPP913999A0 true AUPP913999A0 (en) 1999-04-01

Family

ID=3813338

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPP9139A Abandoned AUPP913999A0 (en) 1999-03-12 1999-03-12 Novel chemical compounds and their use
AU28966/00A Ceased AU774222B2 (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU28966/00A Ceased AU774222B2 (en) 1999-03-12 2000-03-09 Dimeric compounds and their use as inhibitors of neuraminidase

Country Status (26)

Country Link
US (1) US6548476B1 (https=)
EP (1) EP1165541B1 (https=)
JP (1) JP5160000B2 (https=)
KR (1) KR100805906B1 (https=)
CN (1) CN1343205A (https=)
AP (1) AP2001002277A0 (https=)
AT (1) ATE295361T1 (https=)
AU (2) AUPP913999A0 (https=)
BR (1) BR0008939A (https=)
CA (1) CA2367755C (https=)
CZ (1) CZ20013274A3 (https=)
DE (1) DE60020100T2 (https=)
EA (1) EA200100968A1 (https=)
ES (1) ES2241581T3 (https=)
HK (1) HK1041693B (https=)
HU (1) HUP0200190A3 (https=)
ID (1) ID29868A (https=)
IL (1) IL145346A (https=)
MX (1) MXPA01009203A (https=)
NO (1) NO327812B1 (https=)
NZ (1) NZ514041A (https=)
PL (1) PL350228A1 (https=)
TR (1) TR200102794T2 (https=)
TW (1) TWI268279B (https=)
WO (1) WO2000055149A1 (https=)
ZA (1) ZA200107450B (https=)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335368A (en) * 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
DE19930177B4 (de) * 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
AUPQ288499A0 (en) 1999-09-16 1999-10-07 Biota Scientific Management Pty Ltd Antiviral agents
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AU2002340635B2 (en) * 2001-11-09 2008-03-13 Biota Scientific Management Pty Ltd Dimeric compounds and their use as anti-viral agents
AUPR879501A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AU2002340632B2 (en) * 2001-11-09 2008-03-20 Biota Scientific Management Pty Ltd Dimeric compounds and their use as anti-viral agents
AUPR879601A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879401A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AU2002336823B2 (en) * 2001-11-09 2008-03-20 Biota Scientific Management Pty Ltd Dimeric compounds and their use as anti-viral agents
CN1285591C (zh) 2001-11-09 2006-11-22 百奥塔科学管理有限公司 二聚化合物及其作为抗病毒剂的应用
AUPR879701A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
BRPI0314042B8 (pt) * 2002-09-06 2021-05-25 Calando Pharmaceuticals Inc polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
US7317122B2 (en) 2004-12-04 2008-01-08 Xerox Corporation Curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7560587B2 (en) * 2004-12-04 2009-07-14 Xerox Corporation Bis[urea-urethane] compounds
US7314949B2 (en) 2004-12-04 2008-01-01 Xerox Corporation Trans-1,2-cyclohexane bis(urea-urethane) compounds
US7144450B2 (en) * 2004-12-04 2006-12-05 Xerox Corporation Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds
US7576235B2 (en) 2004-12-04 2009-08-18 Xerox Corporation Processes for preparing bis(urea-urethane) compounds
US7153349B2 (en) 2004-12-04 2006-12-26 Xerox Corporation Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7220300B2 (en) 2004-12-04 2007-05-22 Xerox Corporation Phase change inks containing bis(urea-urethane) compounds
US8227425B2 (en) * 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CA2692419C (en) 2007-07-03 2017-12-05 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-n-acetylase and methods for using the same
EP2173759A4 (en) 2007-07-03 2014-01-29 Childrens Hosp & Res Ct Oak OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US20110160159A1 (en) * 2009-09-15 2011-06-30 John Ryan Treatment of cancer
NL2005389A (en) 2009-10-21 2011-04-26 Asml Netherlands Bv Lithographic apparatus, device manufacturing method, and method of applying a pattern to a substrate.
IT1396620B1 (it) * 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
NZ607000A (en) * 2010-08-24 2015-02-27 Imp Innovations Ltd Glycodendrimers of polypropyletherimine
CN104080450A (zh) * 2012-01-05 2014-10-01 阿拉维制药公司 扎那米韦生物利用度增强的制剂
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
US9782476B2 (en) 2013-09-06 2017-10-10 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015148915A1 (en) 2014-03-27 2015-10-01 Academia Sinica Reactive labelling compounds and uses thereof
CA2950423A1 (en) 2014-05-27 2015-12-03 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102512592B1 (ko) 2014-05-27 2023-03-21 아카데미아 시니카 항-ｈｅｒ2 글리코항체 및 이의 용도
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CN106714829A (zh) 2014-05-28 2017-05-24 中央研究院 抗TNF‑α醣抗体及其用途
CA2960712A1 (en) 2014-09-08 2016-03-17 Academia Sinica Human inkt cell activation using glycolipids
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
ES2911027T3 (es) * 2015-11-20 2022-05-17 AusVir Therapeutics Pty Ltd Compuestos para aplicaciones medicinales
RU2612221C1 (ru) * 2015-12-16 2017-03-03 Общество с ограниченной ответственностью "Синтавр" Блокаторы вируса гриппа
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
EP3500594A4 (en) 2016-08-22 2020-03-11 Cho Pharma Inc. ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
CN108003065B (zh) * 2016-10-27 2021-01-08 中国石油化工股份有限公司 一种具有增稠作用的化合物和润滑脂以及它们的制备方法
WO2018199798A1 (ru) * 2017-04-28 2018-11-01 Общество с ограниченной ответственностью "Синтавр" Пептидные производные противовирусного препарата занамивира
US11773129B2 (en) * 2017-05-25 2023-10-03 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
CN111698999A (zh) * 2017-12-06 2020-09-22 阿道恰公司 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph为7的可注射溶液
KR20210079278A (ko) * 2018-09-06 2021-06-29 시다라 세라퓨틱스, 인코포레이티드 바이러스 감염의 치료를 위한 조성물 및 방법
BR112021006403A2 (pt) * 2018-10-05 2021-07-06 Univ Emory agentes monômeros e multiméricos anti-hbv
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050484A1 (en) * 1990-02-27 1991-08-28 Satoru Nakabayashi Sialic acid-containing glycolipid derivatives
ATE193551T1 (de) * 1991-03-18 2000-06-15 Scripps Research Inst Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
CA2129987A1 (en) * 1992-02-19 1993-09-02 Naoya Kojima Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto
JPH0638784A (ja) * 1992-03-30 1994-02-15 Meiji Milk Prod Co Ltd シアル酸を構成要素とする糖鎖の製造方法
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
US5658880A (en) * 1993-06-16 1997-08-19 Glycomed Incorporated Sialic acid/fucose based medicaments
US5837689A (en) * 1993-06-16 1998-11-17 Glycomed Incorporated Sialyl lewis-x mimetics containing naphthyl backbones
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5780606A (en) * 1995-06-07 1998-07-14 Connaught Laboratories Limited Neisseria meningitidis capsular polysaccharide conjugates
CA2245680C (en) 1996-03-01 2005-09-27 Biota Scientific Management Pty. Ltd. Method of detection of influenza virus and compounds for use therein
US5891862A (en) * 1996-03-15 1999-04-06 Geltex Pharmaceuticals, Inc. Polyvalent polymers for the treatment of rotavirus infection
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
JP4179567B2 (ja) * 1996-07-23 2008-11-12 生化学工業株式会社 新規ラクトサミンオリゴ糖およびその製造方法
NZ335368A (en) 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
JPH10182686A (ja) * 1996-12-26 1998-07-07 Ngk Insulators Ltd ガングリオシドＧＱ１ｂ類縁物質
WO1998046279A1 (fr) 1997-04-17 1998-10-22 Johnson & Johnson Medical Kabushiki Kaisha Feuilles indicateurs chimiques et poches pour sterilisation utilisant lesdites feuilles
WO1999063929A2 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein

Also Published As

Publication number Publication date
EA200100968A1 (ru) 2002-02-28
AP2001002277A0 (en) 2001-09-30
NZ514041A (en) 2001-09-28
NO20014409D0 (no) 2001-09-11
HUP0200190A3 (en) 2004-01-28
JP2002539204A (ja) 2002-11-19
BR0008939A (pt) 2001-12-18
KR100805906B1 (ko) 2008-02-21
ZA200107450B (en) 2002-09-10
ID29868A (id) 2001-10-18
US6548476B1 (en) 2003-04-15
PL350228A1 (en) 2002-11-18
AU2896600A (en) 2000-10-04
TR200102794T2 (tr) 2002-09-23
EP1165541A1 (en) 2002-01-02
KR20020005617A (ko) 2002-01-17
EP1165541A4 (en) 2002-06-05
DE60020100T2 (de) 2006-01-19
CA2367755C (en) 2007-08-28
CA2367755A1 (en) 2000-09-21
HK1041693B (en) 2005-10-14
HUP0200190A2 (en) 2002-06-29
CZ20013274A3 (cs) 2002-03-13
TWI268279B (en) 2006-12-11
NO20014409L (no) 2001-11-01
ATE295361T1 (de) 2005-05-15
JP5160000B2 (ja) 2013-03-13
DE60020100D1 (de) 2005-06-16
NO327812B1 (no) 2009-09-28
AU774222B2 (en) 2004-06-17
IL145346A (en) 2005-11-20
IL145346A0 (en) 2002-06-30
WO2000055149A1 (en) 2000-09-21
MXPA01009203A (es) 2002-08-20
HK1041693A1 (en) 2002-07-19
CN1343205A (zh) 2002-04-03
ES2241581T3 (es) 2005-11-01
EP1165541B1 (en) 2005-05-11

Similar Documents

Publication Publication Date Title
AUPP913999A0 (en) Novel chemical compounds and their use
AUPR001000A0 (en) Novel chemical compounds and their use
AUPR879601A0 (en) Novel chemical compounds and their use
ZA200107870B (en) Fused-ring compounds and use thereof.
AU3678100A (en) Biosensor
AU4145200A (en) Cyclic compounds and uses thereof
AU3215500A (en) Compounds and methods
AU7989400A (en) Compounds and methods
AU4431000A (en) Novel use
AU4198299A (en) Compounds and uses thereof
AU1403501A (en) Novel composition and use
AUPR879701A0 (en) Novel chemical compounds and their use
GB9929702D0 (en) Chemical compounds and their uses
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2998700A (en) Organosilicon compounds and uses thereof
AU4432001A (en) Trityl-type compounds and their use
AU5569200A (en) Uracil compounds and use thereof
AU2529501A (en) Macrocyclic compounds and their use
AU2207001A (en) Novel compounds and process
GB9923882D0 (en) Chemical composition
AU6008000A (en) Chemical compounds-ii
AUPQ319799A0 (en) Chemical methods
AU2669501A (en) New use
AUPQ078799A0 (en) New use
AU2669201A (en) Taccalonolides and their use

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 2896600

Country of ref document: AU